Here, we characterize and directly compare the U87-luc2 and U251-RedFLuc GBM models and evaluate several in vitro and in vivo endpoints, including luciferase expression and activity, tumor growth, volume and invasiveness, survival, and ABC transporter expression. This evidence concerns the gene ABCG2 and neoplasm.